Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy (Q36661727)
Jump to navigation
Jump to search
scientific article published on June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy |
scientific article published on June 2008 |
Statements
1 reference
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy (English)
1 reference
Lisa D Volk
1 reference
Michael J Flister
1 reference
Christopher M Bivens
1 reference
Alan Stutzman
1 reference
Neil Desai
1 reference
Vuong Trieu
1 reference
Sophia Ran
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference